Clinical Trials Browser

Phase 1/2 × Enrolling by invitation × Cholangiocarcinoma × Clear all

NCT01868490 2025-02-10

The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells

Phase 1/2 Enrolling by invitation

CNSGastrointestinal

Neuroblastoma, Cholangiocarcinoma